Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-31

Clinical Trial Update: Neurocognitive Enhancement in Major Depressive Disorder [NA]

View source ↗

Summary

The clinical trial investigating neurocognitive enhancement in Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen's University | Conditions: Major Depressive Disorder | NA | Status: COMPLETED